Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mimetic Solutions LLC

This article was originally published in Start Up

Executive Summary

A polymer that responds to a specific protein, peptide, or other biological molecule by rupturing is the underpinning technology for Mimetic Solutions. The company's Affinimers can release encapsulated drugs at specific locations or times. The polymers become "activated" when they interact with the biological molecule to which they've been engineered to respond-insulin, for example, in the presence of a certain amount of glucose. This sets off a series of interactions within the polymer that ultimately lead it to decompose and release its payload.
Advertisement

Related Content

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC091351

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel